Literature DB >> 27209416

JAK2, MPL, and CALR mutations in children with essential thrombocythemia.

Yuko Sekiya1, Yusuke Okuno1, Hideki Muramatsu1, Olfat Ismael1, Nozomu Kawashima1, Atsushi Narita1, Xinan Wang1, Yinyan Xu1, Asahito Hama1, Hiroyuki Fujisaki2, Toshihiko Imamura3, Daiichiro Hasegawa4, Yoshiyuki Kosaka4, Shosuke Sunami5, Yoshitoshi Ohtsuka6, Shouichi Ohga7, Yoshiyuki Takahashi1, Seiji Kojima1, Akira Shimada8.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27209416     DOI: 10.1007/s12185-016-2022-2

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  3 in total

1.  CALR mutations in patients with essential thrombocythemia diagnosed in childhood and adolescence.

Authors:  Fiorina Giona; Luciana Teofili; Sara Capodimonti; Marica Laurino; Maurizio Martini; Deborah Marzella; Giovanna Palumbo; Daniela Diverio; Robin Foà; Luigi Maria Larocca
Journal:  Blood       Date:  2014-06-05       Impact factor: 22.113

Review 2.  Paediatric essential thrombocythaemia: clinical and molecular features, diagnosis and treatment.

Authors:  Rongfeng Fu; Lei Zhang; Renchi Yang
Journal:  Br J Haematol       Date:  2013-08-16       Impact factor: 6.998

3.  JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes.

Authors:  Elisa Rumi; Daniela Pietra; Virginia Ferretti; Thorsten Klampfl; Ashot S Harutyunyan; Jelena D Milosevic; Nicole C C Them; Tiina Berg; Chiara Elena; Ilaria C Casetti; Chiara Milanesi; Emanuela Sant'antonio; Marta Bellini; Elena Fugazza; Maria C Renna; Emanuela Boveri; Cesare Astori; Cristiana Pascutto; Robert Kralovics; Mario Cazzola
Journal:  Blood       Date:  2013-12-23       Impact factor: 22.113

  3 in total
  1 in total

1.  Characteristics and outcomes of patients with essential thrombocythemia or polycythemia vera diagnosed before 20 years of age: a systematic review.

Authors:  Jean-Christophe Ianotto; Natalia Curto-Garcia; Marie Lauermanova; Deepti Radia; Jean-Jacques Kiladjian; Claire N Harrison
Journal:  Haematologica       Date:  2019-01-24       Impact factor: 9.941

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.